Your source for what’s new and important in the drug industry
It used to be that new drugs coming to market could be left to medical professionals and other specialists. That’s no longer the case.
Now, every day seems to bring news of some startling advance. New drugs and drug technologies are revolutionizing medical practice — and breaking budgets. That affects everyone, including doctors, patients and especially those who must pay.
The Optum Rx Drug Pipeline Insights Report can help keep you up to date. Biologics, biosimilars, gene therapies, orphan drugs, lower-cost generics — we cover the most critical developments.
Our most recent reports are available for download, below. Check back on a quarterly basis for the latest drugs to watch.